SCHEMBL13249709

SCHEMBL13249709

N#Cc1ccc(N(c2ccc3c(c2)c2cc([Si](c4ccccc4)(c4ccccc4)c4ccccc4)ccc2n3-c2ccc(F)cc2)c2ccc3c(c2)c2cc([Si](c4ccccc4)(c4ccccc4)c4ccccc4)ccc2n3-c2ccc(F)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
RORC P51449 1/20 0.33
USP14 P54578 3/20 0.32
NR3C1 P04150 2/20 0.32
TDP2 O95551 2/20 0.32
UBE2M P61081 1/20 0.31
DCUN1D1 Q96GG9 1/20 0.31
MIF P14174 1/20 0.31
BRAF P15056 1/20 0.31
KDR P35968 1/20 0.31
JAK2 O60674 1/20 0.31
JAK3 P52333 1/20 0.31
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12721857 0.99 PTGDR2 (0.36) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL12721741 0.98 PTGDR2 (0.35) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL12722027 0.97 RORC (0.37) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL12722017 0.96 RORC (0.36) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL12721995 0.96 RORC (0.36) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL12721902 0.95 PIK3CD (0.35) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL13249721 0.93 PGR (0.32) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL12721910 0.93 PGR (0.32) PGRKDM4ETP53PTGDR2PIK3CD
SCHEMBL13249692 0.92 RORC (0.35) KDM4ERORCUSP14TDP2
SCHEMBL12721697 0.91 RORC (0.35) KDM4ERORCUSP14TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754349-B2 Silanylamine-based compound and organic light-emitting device including organic layer including the silanylamine-based compound SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2010-07-13 US disclosed
US-20080171227-A1 SILANYLAMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE SILANYLAMINE-BASED COMPOUND SAMSUNG SDI CO., LTD. (KR) 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171227-A1 SILANYLAMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE SILANYLAMINE-BASED COMPOUND ADRB2, ADRB1, ADRB3 PGR 1605/4885KDM4E 2582/4885TP53 3539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.